BioSpace News Archive

If you are trying to land your first position in the life sciences industry, the thought of an interview can be even more overwhelming.

Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company engaged in the commercialization and development of innovative anti-infective agents to treat serious infections, today announced its financial results for the three months and year ended December 31, 2019 and recent corporate highlights.

Company reports positive adoption trends for Dialysate Triferic® (ferric pyrophosphate citrate), highlighted by 77% increase in clinics under contract

Adverum Biotechnologies, Inc. reported financial results for the fourth quarter ended December 31, 2019 and provided a corporate update.

In parallel, board and management evaluating all potential strategic alternatives to maximize shareholder value and implementing cost containment efforts

IRIDEX Corporation reported financial results for the fourth quarter ended December 28, 2019.

Marrone Bio Innovations, Inc., an international leader in sustainable bioprotection and plant health solutions, has provided its financial results for the fourth quarter and full year ended December 31, 2019.

Reports Net Revenues of $83.4 Million for the Three Months Ended December 31, 2019

Merus N.V. announced financial results for the fourth quarter and full year ended December 31, 2019, and provided a business update.

ViewRay, Inc. announced financial results for the fourth quarter and full year ended December 31, 2019.